Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nasdaq Biotechnology Ishares ETF (NQ: IBB ) 142.74 +1.23 (+0.87%) Streaming Delayed Price Updated: 2:57 PM EDT, Oct 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nasdaq Biotechnology Ishares ETF < Previous 1 2 3 4 5 6 7 8 9 ... 24 25 Next > Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday? December 20, 2023 Stocks inched higher during midday trading in New York on Wednesday, with the momentum carrying over from the previous day when the tech-heavy Nasdaq 100 achieved fresh record highs. Via Benzinga Biotech Is Coming Back, Can The Run Last? December 11, 2023 The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally. Via Talk Markets MarketBeat Week in Review – 12/4 - 12/8 December 09, 2023 Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week Via MarketBeat Topics Economy Exposures Interest Rates Three Lessons For Investing In Biotech Companies August 23, 2023 Many successful blockbusters started with a small trial. But you should temper your expectations until a larger, more rigorous trial is conducted. Via Talk Markets 3 biotech powerhouses poised to thrive amid sector rebound December 08, 2023 If the newfound support and uptrend in the biotech sector last, as the new year quickly approaches, the biotech sector could shift from lagger to leader. Via MarketBeat Topics ETFs Biotech reversal confirmed: what's ahead for the IBB? December 08, 2023 The recent reversal and reclaim of the significant $124 support level in the IBB holds importance, indicating a potential shift in momentum. Via MarketBeat Topics ETFs Biotech And Healthcare Portfolio Playbook For December 2023/24 November 27, 2023 We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January. Via Talk Markets Are You A Trader Or Investor: Biotech Momentum Is Picking Up November 20, 2023 ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. Via Talk Markets Topics ETFs You Don't Have to Pick a Winner in Biotech. Here's Why. November 18, 2023 If you invest over the long term, you'll increase your chances of victory. Via The Motley Fool Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures November 09, 2023 Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments. Via InvestorPlace Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech November 01, 2023 Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic. Via Talk Markets Exposures COVID-19 Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... October 23, 2023 The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... Via Talk Markets Topics Economy Exposures Economy When News Moves So Fast, Stocks Can Stand Still October 16, 2023 As far as the market goes, it feels like time is standing still. Via Talk Markets Johnson & Johnson Stock: Is Now the Time to Sell? October 14, 2023 Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff Via InvestorPlace Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up October 09, 2023 Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment. Via Talk Markets Fresh Look At Long Bonds September 14, 2023 As long as the S&P 500 outperforms long bonds (TLT) risk is on. Via Talk Markets Topics Bonds Stocks Exposures Debt Markets US Equities Healthcare Playbook Revisited - Growth Plus Value September 13, 2023 Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on. Via Talk Markets Time For Gilead Sciences-Heavy ETFs? September 12, 2023 Gilead Sciences has underperformed the broader market this year by a hefty margin. Via Talk Markets Technical Correction Or Return Of The Bear Market? September 06, 2023 The QQQ chart right now has a few key aspects. Via Talk Markets It’s Really All About the Retail Sector Now September 05, 2023 Should XRT break the July calendar range low, we will once again be talking about the 80-month moving average or the 6–7-year business cycle low. Via Talk Markets The 3 Best Biotech Stocks to Buy Now: September 2023 September 04, 2023 With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize. Via InvestorPlace Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed August 31, 2023 Via Benzinga Topics ETFs Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio? August 30, 2023 It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. Via Talk Markets Topics ETFs Exposures COVID-19 BRICS And The Recent Headline August 23, 2023 At a time when the world is experiencing de-globalization, an alliance of countries including Brazil, Russia, China, South Africa and possibly India is a potential threat to the west. Via Talk Markets The US Dollar And Long Bonds Doing The Dosey Doe August 22, 2023 With BRICS happening ahead of Jackson Hole, it would be good to look at the technical charts on both the dollar and the long bonds. Via Talk Markets 5 Meme Stocks to Sell Immediately, According to AI August 22, 2023 As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Biotechnology On Drugs August 21, 2023 Biotechnology has traded basically sideways since the start of 2023. Via Talk Markets Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner August 21, 2023 Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years. Via Talk Markets 3 Strong Biotech Performers To Watch As Sector Nears Breakout August 17, 2023 As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming. Via MarketBeat Topics ETFs The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 August 17, 2023 This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 24 25 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.